1. Home
  2. PWOD vs LCTX Comparison

PWOD vs LCTX Comparison

Compare PWOD & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWOD
  • LCTX
  • Stock Information
  • Founded
  • PWOD 1934
  • LCTX 1990
  • Country
  • PWOD United States
  • LCTX United States
  • Employees
  • PWOD N/A
  • LCTX N/A
  • Industry
  • PWOD Major Banks
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PWOD Finance
  • LCTX Health Care
  • Exchange
  • PWOD Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • PWOD 227.1M
  • LCTX 110.2M
  • IPO Year
  • PWOD N/A
  • LCTX N/A
  • Fundamental
  • Price
  • PWOD $29.93
  • LCTX $0.55
  • Analyst Decision
  • PWOD
  • LCTX Strong Buy
  • Analyst Count
  • PWOD 0
  • LCTX 5
  • Target Price
  • PWOD N/A
  • LCTX $4.80
  • AVG Volume (30 Days)
  • PWOD 25.1K
  • LCTX 2.9M
  • Earning Date
  • PWOD 01-27-2025
  • LCTX 03-06-2025
  • Dividend Yield
  • PWOD 4.32%
  • LCTX N/A
  • EPS Growth
  • PWOD 20.90
  • LCTX N/A
  • EPS
  • PWOD 2.62
  • LCTX N/A
  • Revenue
  • PWOD $67,724,000.00
  • LCTX $8,719,000.00
  • Revenue This Year
  • PWOD N/A
  • LCTX N/A
  • Revenue Next Year
  • PWOD N/A
  • LCTX $41.15
  • P/E Ratio
  • PWOD $11.18
  • LCTX N/A
  • Revenue Growth
  • PWOD 5.88
  • LCTX N/A
  • 52 Week Low
  • PWOD $17.01
  • LCTX $0.48
  • 52 Week High
  • PWOD $34.56
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • PWOD 45.65
  • LCTX 47.26
  • Support Level
  • PWOD $28.69
  • LCTX $0.51
  • Resistance Level
  • PWOD $30.99
  • LCTX $0.60
  • Average True Range (ATR)
  • PWOD 0.78
  • LCTX 0.04
  • MACD
  • PWOD -0.20
  • LCTX 0.01
  • Stochastic Oscillator
  • PWOD 37.46
  • LCTX 53.85

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: